Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.58 | N/A |
| PEG Ratio (TTM) | 2.06 | N/A |
| P/S Ratio (TTM) | 0.60 | N/A |
| P/B Ratio (TTM) | 3.23 | N/A |
| P/FCF Ratio (TTM) | 7.92 | N/A |
| Price to 5YR AVG Earnings Ratio | 22.98 | N/A |
| Price to 5YR AVG FCF Ratio | 17.60 | N/A |
Profitability (53%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.11% | N/A |
| ROE (TTM) | 26.33% | N/A |
| Net Profit Margin (TTM) | 5.23% | N/A |
| ROIC 5YR AVG | 1.91% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 16.30% | 125.47% | 165.74% |
| Revenue | 1.42% | 12.40% | 19.19% |
| Net Income | 12.16% | 123.21% | 147.72% |
| Cash Flow | 2.24% | 4.87% | 19.14% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.24 | N/A |
| Quick Ratio (TTM) | 1.21 | N/A |
| D/E Ratio (TTM) | 2.14 | N/A |
| Interest Coverage (TTM) | 3.88 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.80 | N/A |
| LTL to 5YR AVG FCF | 53.65 | N/A |
| Shares Outstanding Growth 5YR AVG | -8.05% | N/A |